ATE181332T1 - Vom gtpase-aktivierenden protein (gap) abgeleitete peptide sowie deren diagnostische und therapeutische verwendung - Google Patents

Vom gtpase-aktivierenden protein (gap) abgeleitete peptide sowie deren diagnostische und therapeutische verwendung

Info

Publication number
ATE181332T1
ATE181332T1 AT90914312T AT90914312T ATE181332T1 AT E181332 T1 ATE181332 T1 AT E181332T1 AT 90914312 T AT90914312 T AT 90914312T AT 90914312 T AT90914312 T AT 90914312T AT E181332 T1 ATE181332 T1 AT E181332T1
Authority
AT
Austria
Prior art keywords
peptides
ras
val
arg
gtpase
Prior art date
Application number
AT90914312T
Other languages
English (en)
Inventor
Francis P Mccormick
Gail L Wong
Paul G Polakis
Bonnie Rubinfeld
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE181332T1 publication Critical patent/ATE181332T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90914312T 1989-08-21 1990-08-20 Vom gtpase-aktivierenden protein (gap) abgeleitete peptide sowie deren diagnostische und therapeutische verwendung ATE181332T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39691089A 1989-08-21 1989-08-21

Publications (1)

Publication Number Publication Date
ATE181332T1 true ATE181332T1 (de) 1999-07-15

Family

ID=23569088

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90914312T ATE181332T1 (de) 1989-08-21 1990-08-20 Vom gtpase-aktivierenden protein (gap) abgeleitete peptide sowie deren diagnostische und therapeutische verwendung

Country Status (8)

Country Link
EP (1) EP0491828B1 (de)
JP (1) JPH05500506A (de)
AT (1) ATE181332T1 (de)
AU (2) AU652724B2 (de)
CA (1) CA2065017A1 (de)
DE (1) DE69033166T2 (de)
IL (1) IL95441A0 (de)
WO (1) WO1991002749A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830684A (en) * 1988-08-10 1998-11-03 Chiron Corporation Native type II GAP, methods for purifying various GAPs and uses of GAPs to diagnose cancer
FR2690162B1 (fr) * 1992-04-21 1995-08-04 Rhone Poulenc Rorer Sa Peptides ayant une activite de facteur d'echange du gdp, sequences d'acides nucleiques codant pour ces peptides, preparation et utilisation.
FR2694296B1 (fr) * 1992-07-30 1994-09-02 Rhone Poulenc Rorer Sa Peptides inhibant l'activité des protéines ras, préparation et utilisation.
IL116026A (en) * 1994-11-22 2005-08-31 Rhone Poulenc Rorer Sa Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses
FR2734266B1 (fr) * 1995-05-16 1997-06-20 Rhone Poulenc Rorer Sa Peptides capables de se lier au domaine sh3 de la proteine gap sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
FR2727116B1 (fr) * 1994-11-22 1996-12-20 Rhone Poulenc Rorer Sa Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
US6312941B1 (en) * 1997-11-26 2001-11-06 The Regents Of The University Of Michigan Compositions and methods for identifying signaling pathway agonists and antagonists
AU2001279103A1 (en) * 2000-08-03 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer
CN114269918A (zh) * 2019-08-14 2022-04-01 摩登纳特斯有限公司 用于纯化体外转录的下游产物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466688B1 (de) * 1988-07-08 1997-08-06 Chiron Corporation Gap-gen-sequenzen und diagnoseverwendungen davon
EP0354808B1 (de) * 1988-08-12 1997-12-03 Ligand Pharmaceuticals Incorporated Polypeptid-induzierte monoklonale Rezeptoren gegen Proteinliganden
EP0407543A4 (en) * 1988-12-22 1992-10-14 Fishman, Mark C. Mammalian gap-43 compositions and methods of use

Also Published As

Publication number Publication date
JPH05500506A (ja) 1993-02-04
EP0491828A1 (de) 1992-07-01
IL95441A0 (en) 1991-06-30
DE69033166T2 (de) 1999-12-23
CA2065017A1 (en) 1991-02-22
EP0491828B1 (de) 1999-06-16
AU6424790A (en) 1991-04-03
DE69033166D1 (de) 1999-07-22
AU652724B2 (en) 1994-09-08
WO1991002749A1 (en) 1991-03-07
AU8034694A (en) 1995-02-16

Similar Documents

Publication Publication Date Title
DE69220940T2 (de) Verkürzte Formen den Hepatozyten Wachstumsfaktor (HGF) Rezeptors
Graziadei et al. Co-capping of ras proteins with surface immunoglobulins in B lymphocytes
NO913211L (no) Nytt monoklonalt antistoff mot nytt antigen knyttet til menneske-tumorer.
NO985150L (no) Antigenbindingsfragmenter som spesifikt detekterer cancerceller, nukleotider som koder fragmentene samt anvendelse derav for profylakse og deteksjon av cancere
DE68928069D1 (de) Anti-T-Zell Rezeptordeterminanten zur Behandlung von Autoimmunkrankheiten
ATE181332T1 (de) Vom gtpase-aktivierenden protein (gap) abgeleitete peptide sowie deren diagnostische und therapeutische verwendung
ATE70280T1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
DE69229394D1 (de) Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen
DE69840509D1 (de) Apoptose-bezogene verbindungen und deren verwendung
ATE151078T1 (de) Verfahren und zwischenprodukte synthetischer antikörperderivate
Peitsch et al. Drebrin, an actin-binding, cell-type characteristic protein: induction and localization in epithelial skin tumors and cultured keratinocytes
Zwirner et al. Complement activation in human lymphoid germinal centres
Mikhailova et al. Immunoregulatory properties of hexapeptide isolated from porcine bone marrow cell culture
ATE215830T1 (de) Verfahren zur detektion und behandlung von individuen mit abnormal hla-a2/tyrosinase- peptidantigenen exprimierenden zellen
DE69737815D1 (de) G-protein gekoppelter rezeptor mit vergrösserter, extrazellulärer domäne
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
Schwartz et al. Secretion of adrenocorticotrophin (ACTH) and ACTH precursors in ovine anterior pituitary cells: actions of corticotrophin-releasing hormone, arginine vasopressin and glucocorticoids
ATE296316T1 (de) Gegen menschliches mcm3-protein gerichtete monoklonale antikörper, verfahren zu deren herstellung und deren verwendung
Dallatomasina et al. Spatiotemporal regulation of tumor angiogenesis by circulating chromogranin A cleavage and neuropilin-1 engagement
Katagata et al. Occurrence and comparison of the expressed keratins in cultured human fibroblasts, endothelial cells and their sarcomas
Michaelsen Evidence of 15 S–S Bridges in the Hinge Region of Human 530
Linscott Contamination of commercial rabbit albumin preparations by bovine albumin
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
Nekrasova et al. The synthetic peptide octraphin TPLVTLFK is a selective agonist of nonopioid β-endorphin receptor
Goldrosen et al. Structural and immunological studies of two IgGl-λ myeloma proteins from a single patient

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties